People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HealthBridge Financial, Inc. | — | Healthtech | Series B | $81.1M | $86.7M | 2023 |
| Analyte Health, Inc. | — | Healthtech | Series A | $21.5M | $67.8M | 2012 |
Daniel Malven at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Malven on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dan Malven | 2 | 6 |
| Greg Robinson | 1 | 9 |
| Gian Fulgoni | 1 | 8 |
| Lon Chow | 1 | 7 |
| Matthew McCall | 1 | 7 |
| Adam Koopersmith | 1 | 7 |
| Vance Vanier | 1 | 5 |
| Mike DeVries | 1 | 4 |
| Kevin Weinstein | 1 | 3 |
| Phyllis Whiteley | 1 | 3 |
| Matt Kinley | 1 | 3 |
| Tami Reller | 1 | 2 |
| Mark Chess | 1 | 2 |
| Joseph B. Anderson | 1 | 2 |
| James Slubowski | 1 | 1 |
| Hin-King Tai | 1 | 1 |
| Amy O'Meara Chambers | 1 | 1 |
| Gregory VandenBosch | 1 | 1 |
| Paul Iles | 1 | 1 |
| Daniel Derman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.